Italy vs Papua New Guinea: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Italy
- Papua New Guinea
How they compare
Papua New Guinea currently reports 4,270 deaths against 4,048 deaths in Italy, a difference of 222 deaths.
That makes Papua New Guinea's figure about 1.1 times Italy's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Papua New Guinea ahead.
Italy ranks 45th and Papua New Guinea ranks 42nd of 157 countries.
Italy has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Italy | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 710.23 deaths | 0 deaths | 710.23 deaths | Italy |
| 2000s | 4,451 deaths | 348.4 deaths | 4,103 deaths | Italy |
| 2010s | 4,398 deaths | 2,272 deaths | 2,126 deaths | Italy |
| 2020s | 4,155 deaths | 3,623 deaths | 532.28 deaths | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Italy or Papua New Guinea?
- Papua New Guinea, at 4,270 deaths against 4,048 deaths in Italy as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Italy and Papua New Guinea?
- 222 deaths, with Papua New Guinea ahead.
- How many years of comparable data are there for Italy and Papua New Guinea?
- 35 years are reported by both, from 1990 to 2024.
- How do Italy and Papua New Guinea rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Italy ranks 45th and Papua New Guinea ranks 42nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.